New Techniques for the Evaluation of Penetration Enhancers
ZHU Xue-min1, MA Min1, REN Lue1, DONG Jie1, CHEN Jun1,2*
1. Pharmaceutical Research Laboratory of Chinese Medicine, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; 2. Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China
Abstract��Penetration enhancers (PEs) are commonly used for improving bioavailability of transdermal drug delivery formulations. In the present paper, the new techniques to investigate the penetration enhancement ability, penetration enhancement mechanism and skin safety of PEs were intensively reviewed. The trends of PE research include high throughput evaluation of penetration enhancement ability, micro-molecular research of penetration enhancement mechanism and quantitative characterization of skin safety. Emergence of new techniques provides technical support which is faster, more comprehensive and reliable for the selection and research of penetration enhancers in future.
��ѧ��,����,����,����,�¾�. Ƥ���մٽ������۵��¼���[J]. �й�ҩѧ��־, 2017, 52(15): 1301-1307.
ZHU Xue-min, MA Min, REN Lue, DONG Jie, CHEN Jun. New Techniques for the Evaluation of Penetration Enhancers. Chinese Pharmaceutical Journal, 2017, 52(15): 1301-1307.
VITORINO C, SOUSA J, PAIS A. Overcoming the skin permeation barrier: challenges and opportunities[J]. Curr Pharm Design, 2015, 21(20):2698-2712.
[2]
ALEXANDER A, DWIVEDI S, AJAZUDDIN, et al. Approaches for breaking the barriers of drug permeation through transdermal drug delivery[J]. J Controlled Release, 2012, 164(1):26-40.
[3]
ITA K B. Chemical penetration enhancers for transdermal drug delivery-success and challenges[J]. Curr Drug Deliv, 2015, 12(6):645.
[4]
PARHI R, SURESH P, MONDAL S, et al. Novel penetration enhancers for skin applications: a review[J]. Curr Drug Deliv, 2011, 9(2):219-230.
[5]
KUMAR S, ZAKREWSKY M, CHEN M, et al. Peptides as skin penetration enhancers: mechanisms of action[J]. J Controlled Release, 2015, 199:168-178.
[6]
DAVIES D J, WARD R J, HEYLINGS J R. Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studies[J]. Toxicol In Vitro, 2004, 18(18):351-358.
[7]
KARANDE P, JAIN A, MITRAGOTRI S. Relationships between skin��s electrical impedance and permeability in the presence of chemical enhancers[J]. J Controlled Release, 2006, 110(2):307-313.
[8]
HORITA D, TODO H, SUGIBAYASHI K. Effect of ethanol pretreatment on skin permeation of drugs[J]. Biol Pharm Bull, 2012, 35(8):1343-1348.
[9]
RACHAKONDA V K, YERRAMSETTY K M, MADIHALLY S V, et al. Screening of chemical penetration enhancers for transdermal drug delivery using electrical resistance of skin[J]. Pharm Res, 2008, 25(11):2697-2704.
[10]
KANSY M, SENNER F, GUBERNATOR K. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes[J]. J Med Chem, 1998, 41(7):1007-1010.
[11]
MIKI R, ICHITSUKA Y, YAMADA T,et al. Development of a membrane impregnated with a poly(dimethylsiloxane)/poly(ethylene glycol) copolymer for a high-throughput screening of the permeability of drugs, cosmetics, and other chemicals across the human skin[J]. Eur J Pharm Sci, 2014, 66:41-49.
[12]
SINK�| B, GARRIGUES T M, BALOGH G T, et al. Skin-PAMPA: a new method for fast prediction of skin penetration[J]. Eur J Pharm Sci, 2012, 45(5):698-707.
[13]
BAL��ZS B, VIZSER��LEK G, BERK S, et al. Investigation of the efficacy of transdermal penetration enhancers through the use of human skin and a skin mimic artificial membrane[J]. J Pharm Sci, 2016, 105(3):1134-1140.
[14]
FLATEN G E, DHANIKULA A B, LUTHMAN K, et al. Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion[J]. Eur J Pharm Sci, 2006, 27(1):80-90.
[15]
PALAC Z, ENGESLAND A, FLATEN G E, et al. Liposomes for (trans)dermal drug delivery: the skin-PVPA as a novel in vitro stratum corneum model in formulation development[J]. J Liposome Res, 2014, 24(4):313-322.
[16]
ZHANG H, ZHU X, SHEN J, et al. Characterization of a liposome-based artificial skin membrane for in vitro permeation studies using Franz diffusion cell device[J]. J Liposome Res, 2016,doi:10.1080/08982104.2016.1231205.
[17]
ENGESLAND A, KALKO-BASNET N, FLATEN G E. In vitro models to estimate drug penetration through the compromised stratum corneum barrier[J]. Drug Dev Ind Pharm, 2016,42(11):1742-1751.
[18]
ERD F, HASHIMOTO N, KARVALY G, et al. Critical evaluation and methodological positioning of the transdermal microdialysis technique:a review[J]. J Controlled Release, 2016, 233:147-161.
[19]
XIE F, CHAI J K, HU Q, et al. Transdermal permeation of drugs with differing lipophilicity: effect of penetration enhancer camphor[J]. Int J Pharm, 2016, 507(1-2):90-101.
[20]
SUBONGKOT T, WONGLERTNIRANT N, SONGPRAKHON P, et al. Visualization of ultradeformable liposomes penetration pathways and their skin interaction by confocal laser scanning microscopy[J]. Int J Pharm , 2012, 441(1-2):151-161.
[21]
CHEN Y, CUN D, QUAN P, et al. Saturated long-chain esters of isopulegol as novel permeation enhancers for transdermal drug delivery[J]. Pharm Res, 2014, 31(8):1907-1918.
[22]
PYATSKI Y, ZHANG Q, MENDELSOHN R, et al. Effects of permeation enhancers on flufenamic acid delivery in ex vivo human skin by confocal Raman microscopy[J]. Int J Pharm, 2016, 505(1):319-328.
[23]
M��LOT M, PUDNEY P D A, WILLIAMSON A M, et al. Studying the effectiveness of penetration enhancers to deliver retinol through the stratum cornum by in vivo confocal Raman spectroscopy[J]. J Controlled Release, 2009, 138(1):32-39.
[24]
FRANZEN L, WINDBERGS M. Applications of Raman spectroscopy in skin research--From skin physiology and diagnosis up to risk assessment and dermal drug delivery[J]. Adv Drug Deliv Rev, 2015, 89:91-104.
[25]
SONGKRO S. An overview of skin penetration enhancers: penetration enhancing activity, skin irritation potential and mechanism of action[J]. Songklanakarin J Sci Technol, 2009, 31(3):299-321.
[26]
WANG J, DONG C, SONG Z, et al. Monocyclic monoterpenes as penetration enhancers of ligustrazine hydrochloride for dermal delivery[J]. Pharm Dev Technol, 2017,22(4):571-577.
[27]
AL-SAIDAN S M, BARRY B W, WILLIAMS A C. Differential scanning calorimetry of human and animal stratum corneum membranes[J]. Int J Pharm, 1998, 168(1):17-22.
[28]
SILVA C L, NUNES S C, EUS��BIO M E, et al. Thermal behaviour of human stratum corneum. A differential scanning calorimetry study at high scanning rates[J]. Skin Pharmacol Phys, 2006, 19(3):132-139.
[29]
IBRAHIM S A, LI S K. Chemical enhancer solubility in human stratum corneum lipids and enhancer mechanism of action on stratum corneum lipid domain[J]. Int J Pharm, 2010, 383(2):89-98.
[30]
VASHISTH I, AHAD A, AQIL M, et al. Investigating the potential of essential oils as penetration enhancer for transdermal losartan delivery: effectiveness and mechanism of action[J]. Asian J Pharm Sci, 2014, 9(5):260-267.
[31]
AHAD A, AQIL M, KOHLI K, et al. Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action[J]. Drug Dev Ind Pharm, 2011, 37(5):583-596.
[32]
HOPPEL M, BAURECHT D, HOLPER E, et al. Validation of the combined ATR-FTIR/tape stripping technique for monitoring the distribution of surfactants in the stratum corneum[J]. Int J Pharm, 2014, 472(1-2):88-93.
[33]
HE W, GUO X, XIAO L, et al. Study on the mechanisms of chitosan and its derivatives used as transdermal penetration enhancers[J]. Int J Pharm, 2009, 382(1-2):234-243.
[34]
ERDAL M S, ZDIN D, G�^NG R S. Synergistic effects of transcutol and terpenes as penetration enhancers: in vitro and in vivo ATR-FTIR spectroscopic imaging studies[J]. Issues Toxicol, 2013:113-123.
[35]
HATTA I, OHTA N, INOUE K, et al. Coexistence of two domains in intercellular lipid matrix of stratum corneum[J]. BBA-Biomembranes, 2006, 1758(11):1830-1836.
[36]
MOJUMDAR E H, GOORIS G S, GROEN D, et al. Stratum corneum lipid matrix: location of acyl ceramide and cholesterol in the unit cell of the long periodicity phase[J]. BBA-Biomembranes, 2016, 1858(8):1926-1934.
[37]
RAJAB N A, RASSOL A A A, ASSAF S M, et al. Preparation and evaluation of Fentanyl transdremal patches using lidocaine as a model drug and azelaic acid as a penetration enhancer[J]. Int J Pharm Pharm Sci, 2014, 6(7):615-620.
[38]
FURUISHI T, KATO Y, FUKAMI T, et al. Effect of terpenes on the skin permeation of lomerizine dihydrochloride[J]. J Pharm Pharm Sci, 2013, 16(4):551-563.
[39]
LAN Y, WANG J, HE S, et al. Transdermal permeation of Zanthoxylum bungeanum essential oil on TCM components with different lipophilicity[J]. J Tradit Chin Med Sci, 2016,3(3):157-167.
[40]
YANG S, WANG R, WAN G, et al. A multiscale study on the penetration enhancement mechanism of menthol to osthole[J]. J Chem Inf Model, 2016, 56(11):2234-2242.
[41]
KANIKKANNAN N, SINGH M. Skin permeation enhancement effect and skin irritation of saturated fatty alcohols[J]. Int J Pharm, 2002, 248(1-2):219-228.
[42]
YAN Y, XING J, XU W, et al. Hydroxypropyl-��-cyclodextrin grafted polyethyleneimine used as transdermal penetration enhancer of diclofenac sodium[J]. Int J Pharm, 2014, 474(1-2):182-192.
[43]
YI Q F, YAN J, TANG S Y, et al. Effect of borneol on the transdermal permeation of drugs with differing lipophilicity and molecular organization of stratum corneum lipids[J]. Drug Dev Ind Pharm, 2016, 42(7):1-8.
[44]
MONTI D, EGIZIANO E, BURGALASSI S, et al. Ionic liquids as potential enhancers for transdermal drug delivery[J]. Int J Pharm, 2016, 516(1-2):45-51.
[45]
MORALES M, P�FREZ D, CORREA L, et al. Evaluation of fibrin-based dermal-epidermal organotypic cultures for in vitro skin corrosion and irritation testing of chemicals according to OECD TG 431 and 439[J]. Toxicol In Vitro, 2016, 36:89-96.
[46]
DANILENKO D M, PHILLIPS G D, DIAZ D. In vitro skin models and their predictability in defining normal and disease biology, pharmacology, and toxicity[J]. Toxicol Pathol, 2016, 44(4):555-563.
[47]
GUTH K, SCH�CFER-KORTING M, FABIAN E, et al. Suitability of skin integrity tests for dermal absorption studies in vitro[J]. Toxicol In Vitro, 2014, 29(1):113-123.
[48]
KARANDE P, JAIN A, ERGUN K, et al. Design principles of chemical penetration enhancers for transdermal drug delivery[J]. Proc Natl Acad Sci USA, 2005, 102(13):4688-4693.
[49]
JANUSOV�� B, SKOLOV�� B, T��K��ROV����K, et al. Amino acid derivatives as transdermal permeation enhancers[J]. J Controlled Release, 2013, 165(2):91-100.
[50]
SIRAEVA Z, D�BNG T, YERGESHOV A, et al. Evaluation of skin irritation in rats using simultaneous laser Doppler flowmetry and oxygenation monitoring[J]. Bio Nano Sci, 2016,6:384-387.
[51]
CHEN J, JIANG Q D, WU Y M, et al. Potential of essential oils as penetration enhancers for transdermal administration of ibuprofen to treat dysmenorrhoea[J]. Molecules, 2015, 20(10):18219-18236.
[52]
BAI Y, DU L N, FENG X, et al. Progress of transdermal drug delivery systems for natural drugs[J]. Chin Pharm J ( �й�ҩѧ��־), 2014, 49(16) : 1377-1381.
2017, Vol. 52 
